Bios Equity Partners LP 13D and 13G filings for Lantern Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-13 7:43 pm Sale | 2025-06-12 | 13D | Lantern Pharma Inc. LTRN | Bios Equity Partners LP | 1,075,952 9.980% | -187,850 (-14.86%) | Filing |
| 2024-03-01 4:10 pm Sale | 2024-02-28 | 13D | Lantern Pharma Inc. LTRN | Bios Equity Partners LP | 1,263,802 11.800% | -202,889 (-13.83%) | Filing |
| 2023-12-01 06:02 am Sale | 2023-11-29 | 13D | Lantern Pharma Inc. LTRN | Bios Equity Partners LP | 1,466,691 13.600% | -508,150 (-25.73%) | Filing |
| 2022-03-22 4:15 pm Purchase | 2022-03-17 | 13D | Lantern Pharma Inc. LTRN | Bios Equity Partners LP | 1,974,841 18.100% | 5,855 (+0.30%) | Filing |